Lacticaseibacillus casei and treatment adherence: Evidence review
This conversation examines whether Lacticaseibacillus casei improves adherence to treatment plans. The assistant explains that current research focuses on digestive, metabolic, and immune outcomes, with no studies directly linking this probiotic to behavioral compliance.
Does taking Lacticaseibacillus casei actually help people stick to their treatment plans, or is there not much evidence for that?
Based on the available research, there does not appear to be evidence supporting the idea that Lacticaseibacillus casei helps people adhere to their treatment plans.
Here's what Pillser's research database shows for this probiotic:
- 10 health outcomes have been studied in relation to Lacticaseibacillus casei, including reduced body weight, improved bowel function, reduced diarrhea rate, improved natural killer cell activity, reduced blood glucose levels, and reduced liver enzyme levels1.
- None of these outcomes relate to treatment adherence or compliance.
I also searched for authoritative sources connecting Lacticaseibacillus casei to treatment adherence, and no relevant results were found.
In short, there is not much evidence — in fact, there appears to be no research directly examining whether this probiotic influences how well people stick to their treatment plans. The studied effects of Lacticaseibacillus casei are focused on digestive health, metabolic markers, and immune function, not behavioral outcomes like adherence.
Footnotes
-
Pillser research database, Lacticaseibacillus casei. ↩